BEXKIN

This brand name is authorized in Nigeria.

Active ingredients

The drug BEXKIN contains one active pharmaceutical ingredient (API):

1	Ketoconazole UNII R9400W927I - KETOCONAZOLE
	Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes.
	Read more about Ketoconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100385	Cream	BEXKIN CREAM CREAM 2%	BEXKIN CREAM KETOCONAZOLE BP 2%W/W KETOCONAZOLE BP 2%W/W Drugs Imported Products 1X30GX10TUBES OTC 21/03/2023 TOP UGOLIFE PHARMACEUTICAL CO LTD, 13, JOSEPH ADEBAYOR STREET, AGO PALACE, OKOTA , LAGOS STATE. 8063125746 eugo37@yahoo.com ASTAMED HEALTHCARE (I) PVT LTD, Plot No. 2 & 3, Pase II, Genesis Ind. Complex, Kolgaon, Palghar - 401405, Maharashtra, India, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AC08	Ketoconazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100385